p73 keeps metabolic control in balance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer.Molecular oncology · 2022
   Article
2. Expression and clinical significance of p73 in Wilms tumor in children.Oncology letters · 2019
   Article
3. The Role of Genetic Polymorphisms in Nrf2 and P73 in Egyptian Women with Breast CancerAsian Pacific journal of cancer prevention : APJCP · 2016
   Article
4. Metabolic pathways regulated by TAp73 in response to oxidative stress.Oncotarget · 2016
   Article
5. Structure and apoptotic function of p73.BMB reports · 2015
   Review
6. Bioinformatics analysis of the serine and glycine pathway in cancer cells.Oncotarget · 2014
   Article

Corrections and comments

• Comment on
  GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as